MedDataX Logo

Physician Self Disclosure of IUC Use

NCT ID: NCT01994356

Last Updated: 2013-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do. This begs the question: Might physician self-disclosure of personal IUC use increase IUC use among patients? However, the positive or negative impact of physician self disclosure on IUC uptake or patient satisfaction is generally unknown. The purpose of this study was to evaluate if physician self-disclosure of personal IUC use increases patient use of IUC or impacts patients' satisfaction with their clinical encounter.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We performed a prospective randomized block design pilot trail of usual contraceptive counseling versus usual counseling plus physician self-disclosure of personal intrauterine contraceptive use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Contraceptive counseling Physician self disclosure Satisfaction Intrauterine contraceptive use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual contraceptive counseling

subjects received usual contraceptive counseling

Group Type ACTIVE_COMPARATOR

Usual contraceptive counseling

Intervention Type BEHAVIORAL

all subjects recieved usual contraceptive counseling

Physician self-disclosure of IUC use

subjects received usual contraceptive counseling plus intervention which was Physician self-disclosure of personal IUC use during the counseling

Group Type EXPERIMENTAL

Physician self-disclosure of personal IUC use

Intervention Type BEHAVIORAL

Physicians self-disclosed personal intrauterine contraceptive use to subjects in intervention arm of study during contraceptive counseling

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physician self-disclosure of personal IUC use

Physicians self-disclosed personal intrauterine contraceptive use to subjects in intervention arm of study during contraceptive counseling

Intervention Type BEHAVIORAL

Usual contraceptive counseling

all subjects recieved usual contraceptive counseling

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

contraceptive counseling

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* reproductive age
* currently sexually active
* scheduled for benign gynecology visit, annual exam, or family planning visit

Exclusion Criteria

* seeking pregnancy within 1 year
* currently using IUC
* prior sterilization procedure
* currently pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mya Zapata

Clinical Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan Medical Center

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N014264

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

IUC Disclosure

Identifier Type: -

Identifier Source: org_study_id